Cancer Med, Rituximab, Might Be Powerful Treatment for MS
THURSDAY, July 14, 2022 -- A drug used " off-label " for multiple sclerosis (MS) is more effective than a standard medication at preventing symptom flare-ups, a new clinical trial has found.
The drug, called rituximab, is approved in the United...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | General Medicine | Multiple Sclerosis | Rituxan